EFSA has finalised its assessment of the risks to public health from acrylamide in food. Due to concerns over genotoxicity, no health guidance values were derived, and a margin of exposure (MoE) approach was instead used for risk assessment. Carcinogenic effects in mice and peripheral neuropathy in rats were considered critical. While current levels of dietary exposure to acrylamide are not considered to be of concern for peripheral neuropathy, EFSA noted potential concerns for cancer, although no epidemiological evidence was identified to suggest that acrylamide is a human carcinogen.

European Food Safety Authority (2015). Panel on Contaminants in the Food Chain (CONTAM). Scientific opinion on acrylamide in food. EFSA Journal 2015, 13(6), 4104. http://www.efsa.europa.eu/en/efsajournal/doc/4104.pdf

 

 

The above items were taken from the July 2015 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here)

News Home Guest Write For Us? Contact Us